News & Articles

First human trials examine the impact of dark chocolate consumption on cognition and other brain functions

AACR and CRUK, two of the biggest cancer research committees around the globe to join force to aid the development of cancer therapeutics

The highly anticipated platform was launched by Repositive at AACR annual meeting

NYU school of medicine becomes the most recent cancer center to join PanFAM-1 prospective study

The trial demonstrates that first-line pembrolizumab treatment improved overall and progression-free survival rates in patients with metastatic nonsquamous non-small cell lung cancer

The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer

Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer

A recent study from University of Edinburgh aims to pinpoint genes that may be associated with depression

Crizotinib yielded a high objective response rate for adult patients with ALK-positive Inflammatory myofibroblastic tumor, and a 100 percent disease control rate

Research reveals that acquired HER2 mutations confer resistance to hormone therapy in ER-positive metastatic breast cancer

The HeraSafe 2030i BSC is designed to optimize contamination control and accelerate productivity across challenging cell culture applications